Compliance Rate
Compliance Rate
25.0%
Compliant submissions
2
Incompliant submissions
6
Total trials
8
My Organizations' Clinical Trials
Showing 475 of 1120 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/01/20
End: 03/01/20
Due: 03/01/21
Phase: N/A
Priority: Normal
Start: 11/30/10
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 12/31/06
End: 09/30/07
Due: 09/30/08
Phase: N/A
Priority: Normal
Start: 04/30/16
End: 05/31/24
Due: 05/31/25
Phase: N/A
Priority: Normal
Start: 05/31/12
End: 05/31/14
Due: 05/31/15
Phase: N/A
Priority: Normal
Start: 05/15/19
End: 11/01/21
Due: 11/01/22
Phase: N/A
Priority: Normal
Start: 11/30/09
End: 07/31/15
Due: 07/31/16
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 06/20/23
Due: 06/20/24
Phase: N/A
Priority: Normal
Start: 03/01/23
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 02/26/18
End: 03/25/20
Due: 03/25/21
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 03/31/11
Due: 03/31/12
Phase: N/A
Priority: Normal
Start: 01/31/06
End: 09/30/06
Due: 09/30/07
Phase: N/A
Priority: Normal
Start: 12/31/15
End: 11/07/21
Due: 11/07/22
Phase: N/A
Priority: Normal
Start: 04/30/01
End: 07/31/05
Due: 07/31/06
Phase: N/A
Priority: Normal
Start: 08/31/10
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 03/27/18
End: 02/28/19
Due: 02/28/20
Phase: N/A
Priority: Normal
Start: 04/30/11
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 04/01/14
End: 04/08/20
Due: 04/08/21
Phase: N/A
Priority: Normal
Start: 02/28/09
End: 01/31/13
Due: 01/31/14
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 02/28/09
Due: 02/28/10
Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot Study
Phase: N/A
Priority: Normal
Start: 01/31/09
End: 02/28/11
Due: 02/28/12
Phase: N/A
Priority: Normal
Start: 11/30/14
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 05/31/08
End: 11/30/10
Due: 11/30/11
Phase: N/A
Priority: Normal
Start: 05/31/09
End: 02/28/10
Due: 02/28/11
Phase: N/A
Priority: Normal
Start: 12/31/11
End: 01/31/14
Due: 01/31/15